Lactoferrin modifies apoptosis-related gene expression in the colon of the azoxymethane-treated rat

Cancer Lett. 2004 Sep 15;213(1):21-9. doi: 10.1016/j.canlet.2004.03.029.

Abstract

Lactoferrin, an iron-binding glycoprotein, exhibits suppressive effects on development of azoxymethane (AOM)-induced tumors in the rat colon, but the mechanisms are largely unknown. In this study, we investigated the effect of lactoferrin on the gene expression of 10 apoptosis-related molecules in colon mucosa of AOM-treated rats during early and late stages of colon carcinogenesis by reverse transcription PCR. Here we document that a death-inducing receptor, Fas, and a pro-apoptotic Bcl-2 family member, Bid, are increased in the colon mucosa in proportion to decreases in AOM-induced aberrant crypt foci by lactoferrin. Similarly, increased expression of the pro-apoptotic Bcl-2 family member, Bax, was also observed in AOM-induced tumors in rats fed by lactoferrin. These results indicate that Fas and pro-apoptotic Bcl-2 members participate in the lactoferrin action and may contribute to suppressive effects on tumor development in the rat colon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Animals
  • Apoptosis / drug effects*
  • Apoptosis / genetics*
  • Azoxymethane / toxicity*
  • Carcinogens / toxicity*
  • Cell Transformation, Neoplastic
  • Chemoprevention
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / physiopathology*
  • Colonic Neoplasms / veterinary
  • Cyclin D1 / biosynthesis*
  • Disease Models, Animal
  • Fas Ligand Protein
  • Gene Expression Regulation / drug effects*
  • Lactoferrin / administration & dosage
  • Lactoferrin / pharmacology*
  • Male
  • Membrane Glycoproteins / biosynthesis*
  • Rats
  • Rats, Inbred F344
  • Up-Regulation

Substances

  • Carcinogens
  • Fas Ligand Protein
  • Faslg protein, rat
  • Membrane Glycoproteins
  • Cyclin D1
  • Lactoferrin
  • Azoxymethane